Topical KUVA (Khellin-UVA therapy)- A future in the treatment of vitiligo?

Anstey, Alexander Vincent ORCID: https://orcid.org/0000-0002-6345-4144 1998. Topical KUVA (Khellin-UVA therapy)- A future in the treatment of vitiligo? Journal of Dermatological Treatment 9 (2) , pp. 63-64. 10.3109/09546639809161374

Full text not available from this repository.

Abstract

The chief hazard associated with topical photochemo-therapy is a severe phototoxic reaction which occasionally happens despite the best of care and caution in regulating UV exposure. This cannot obviously be achieved with sunlight. Furthermore, due to their extreme photosensitivity, topical psoralens are difficult to use in vitiligo patients. In one clinical study with topical 8-MOP, and carefully controlled UV-irradiations, erythema and blistering were observed, in 71% and 18% of the patients respectively.1 Only a few studies have been performed with topical TMP in the treatment of vitiligo. This compound, even at very small amounts, can also induce severe phototoxic reactions.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > RL Dermatology
Publisher:	Informa
ISSN:	1471-1753
Last Modified:	21 Oct 2022 09:23
URI:	https://orca.cardiff.ac.uk/id/eprint/36166

Citation Data

Cited 1 time in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item